Founded in 2010, Biomeostasis is a leading Preclinical CRO that offers in vivo research services in the fields of Metabolic, GastroIntestinal & Muscle-Wasting Diseases.

For over 15 years, we have been assessing the Efficacy & Mechanisms of action of Health Products that address conditions such as Obesity, Diabetes, MASLD/MASH, Atherosclerosis, Binge-eating, IBD, Sarcopenia, Cachexia, Duchenne Muscular Dystrophy (DMD)...


Complementary to our in vivo pharmacology services, we offer Histology and Omics enabling deciphering the efficacy and MoA of Health Products in the metabolic, GI and muscle-wasting spaces.

Localisation : Marseille - France

Biomeostasis

Org chart

Teams

Offices